Reimbursement decisions for in-vitro diagnostic tests in 2018 in Europe

Syndicated report on all published reimbursement decisions for IVD tests in 2018 in European countries with established frameworks for out-patient reimbursement laboratory tests

Request a quote

In-vitro diagnostic tests have specific reimbursement framework compared with medical devices.

In most of the European countries, IVD tests, that are performed at hospital are included into DRG tariff and laboratories are funded using a global budget principle.

However, in out-patient settings, many countries have specific reimbursement frameworks for IVD tests, most commonly using a fee for service payment model.

In this report, we summarized reimbursement decisions for IVD tests in 2018 in the countries, where explicit reimbursement framework exists (Belgium, France, Germany, Netherlands, Switzerland). 

Why this report can be of interest to IVD industry?

  • First, it can indicate the level of activity of reimbursement authorities in different European countries. Knowledge, about how often new tests are added to reimbursement nomenclatures can support planning of reimbursement activities. Should you consider Belgium or Germany for market entry, or is it better to focus on France? Our report can help find answers to these questions
  • Second, knowledge of what tests were added to the reimbursement nomenclature can support decision-making about evidence requirements for reimbursement registration

Key features of the report

5 EU countries

Reimbursement decisions were collected in the countries, where specific reimbursement frameworks exist (Belgium, France, Germany, Netherlands, Switzerland)

Brief overview of system

Brief overview of reimbursement framework in each country is provided

List of all published decisions (>55)

All decisions per country are listed in the table format including name of the test, the reimbursement tariff and web-link

Obtain sample pages

Click to the link below to obtain sample pages, including description of the reimbursement framework and examples of reimbursement decisions in Belgium

Get sample pages

Specifics of the report

Belgium: IVD tests included into INAMI Nomenclature in 2018

France: IVD tests include into NABM and RIHN (innovative tests) Nomenclatures in 2018

Germany: IVD tests included into EBM nomenclature in 2018

Netherlands: IVD tests included into reimbursement list of Dutch Health Care Authority (NZa) in 2018

Switzerland: IVD tests included into List of Analyses (Annex 3 of the KLV List) in 2018

Request a quote

Click the button below to request a quote for the report

Close

50% Complete

Two Step

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.